![JDMF 220MF10122 of Teva Czech Industries S. R. O. | Japan Drug Master Files | JP DMF | Pharmacompass.com JDMF 220MF10122 of Teva Czech Industries S. R. O. | Japan Drug Master Files | JP DMF | Pharmacompass.com](https://www.pharmacompass.com/image/banner/teva-api-newgif-1649064651.gif?w=1200&h=630)
JDMF 220MF10122 of Teva Czech Industries S. R. O. | Japan Drug Master Files | JP DMF | Pharmacompass.com
![Teva Pharmaceutical USA, Inc. (a subsidiary of Teva Pharmaceutical Industries Ltd.), Pfizer Inc. and Novartis AG are Dominating in the U.S. Membranous Nephropathy Market in 2020 | Data Bridge Market Reseach Teva Pharmaceutical USA, Inc. (a subsidiary of Teva Pharmaceutical Industries Ltd.), Pfizer Inc. and Novartis AG are Dominating in the U.S. Membranous Nephropathy Market in 2020 | Data Bridge Market Reseach](https://www.databridgemarketresearch.com/media/2021/3/2a4a8bcf-a9d3-46c4-8154-e30ef8d06f75.jpg)
Teva Pharmaceutical USA, Inc. (a subsidiary of Teva Pharmaceutical Industries Ltd.), Pfizer Inc. and Novartis AG are Dominating in the U.S. Membranous Nephropathy Market in 2020 | Data Bridge Market Reseach
![Teva Pharmaceuticals USA, Inc., Viatris Inc., and Novartis AG dominated the North America IgA Nephropathy Market in 2020 | Data Bridge Market Reseach Teva Pharmaceuticals USA, Inc., Viatris Inc., and Novartis AG dominated the North America IgA Nephropathy Market in 2020 | Data Bridge Market Reseach](https://www.databridgemarketresearch.com/media/2021/10/1605e62e-e8ed-40c3-9706-30a0718ee54b.jpg)